跳至主要内容
临床试验/NCT02752997
NCT02752997已完成不适用

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2015年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
24
试验地点
1
主要终点
Number of patients readmitted to the hospital within 30 days of primary heart failure admission

研究概览

简要总结

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Diagnosis of heart failure, discharged from any medical service

排除标准

  • •Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

研究组 & 干预措施

Intervention

Experimental

Discharge medication services included:

  • Discharge medication reconciliation
  • Identification of medication discrepancies and resolution
  • Medication counseling using health coaching techniques with short term goal setting and follow up phone call

干预措施: Pharmacist discharge medication services (Other)

Comparator

No Intervention

Current standard of care provided by nursing staff.

结局指标

主要结局

Number of patients readmitted to the hospital within 30 days of primary heart failure admission

时间窗: 30 Days

Fisher's T-test

次要结局

  • Number of patients who visit the emergency department within 30 days of primary heart failure admission(30 Days)
  • Number of short term goals set by patient's at discharge and the number of short term goals met by patient's at the 7-10 follow up phone call.(30 days)
  • Number of medication discrepancies identified and the number of medication discrepancies resolved by the pharmacist at discharge.(30 Days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Lessard

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验